A Prospective Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain
A Prospective Controlled Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain
Sponsor: GENOS
A observational or N/A phase clinical study on Acute Low Back Pain and Chronic Low Back Pain, this trial is ongoing. The trial is conducted by GENOS and has accumulated 12 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 7 earlier versions
-
Feb 2019 — Nov 2020 [monthly]
Unknown Status
-
Oct 2018 — Feb 2019 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Oct 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GENOS
- Helmholtz Zentrum München
- Ip Research Consulting Sasu
- King's College London
- University of Parma
- YURII AULCHENKO
For direct contact, visit the study record on ClinicalTrials.gov .